Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 28, 2026Reported purchase · Form 4JOANNE WENDY KIM, Chief Financial Officer · $5.5KOpen the filing ↗
- Aug 28, 2026Reported purchase · Form 4Amy Suzon Chappell · $1.6KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record4577 flagged findings
Reported transactions (Form 4)76since Nov 23, 2022
Corporate events (8-K)30since May 10, 2021
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Reverse splits in 5 years
1 reverse split in 5 years (1:10 on Jul 7, 2025) · 1:10 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 457)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 28, 26DEF 14A ↗Shareholder meeting and votes
- Sep 14, 268-K ↗Current report · Entered a material agreement
- Sep 14, 26424B5 ↗Securities offering
- Sep 3, 26SCHEDULE 13G ↗Passive stake · JANE STREET GROUP, LLC · 5.2% · event on Aug 28, 26
- Aug 19, 26SCHEDULE 13G ↗Passive stake · Alta Partners LLC · 8.4% · event on Aug 12, 26
- Aug 14, 26S-1/A ↗Securities offering · amendment
- Aug 13, 2610-K ↗Annual report
- Aug 7, 26SCHEDULE 13G/A ↗Passive stake · Morgan Stanley · 11.9% · event on Jul 31, 26 · amendment
- Aug 7, 26SCHEDULE 13G ↗Passive stake · Morgan Stanley · 8.0% · event on Jun 30, 26
- Aug 6, 26S-1/A ↗Securities offering · amendment
- Aug 6, 268-K ↗Current report · Communication to the market
- Jul 31, 26S-1/A ↗Securities offering · amendment
- Jul 17, 26S-1 ↗Securities offering
- Jun 18, 26S-3 ↗Securities offering
- May 11, 2610-Q ↗Quarterly report
- Mar 25, 26SCHEDULE 13D ↗Stake with intent to influence · DO CUONG V · 5.0% · event on Jan 5, 26
- Feb 6, 2610-Q ↗Quarterly report
457 filings on record, the oldest from Aug 15, 13.
Listing the 25 most recent filings of the 457 on record.
14825
- Sep 14, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Nov 13, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Aug 11, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jul 23, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Mar 28, 25A senior executive left or was appointed8-K 5.02 ↗
4 material agreements entered2024show all 4hide
- Oct 29, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Oct 24, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Oct 22, 24Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Sep 24, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jul 30, 24A senior executive left or was appointed8-K 5.02 ↗
- Apr 19, 24Listing notice (8-K 3.01)8-K 3.01 ↗
- Mar 4, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Mar 6, 23A senior executive left or was appointed8-K 5.02 ↗
3 material agreements entered2022show all 3hide
- Aug 31, 22Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jul 18, 22Entered a material agreement+2 more in the same filing8-K/A 1.01 ↗
- Jul 15, 22Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jun 29, 22Took on a new financial obligation+2 more in the same filing8-K 2.03 ↗
4 older filings not shown · The record reaches back to Aug 28, 14.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- ACUITAS GROUP HOLDINGS, LLC15.8%Jun 25, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- DO CUONG V5.0%Jan 5, 26SCHEDULE 13D ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Morgan Stanley11.9%Jul 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Alta Partners LLC8.4%Aug 12, 26SCHEDULE 13G ↗
- JANE STREET GROUP, LLC5.2%Aug 28, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Aug 28, 26Buy$5KJOANNE WENDY KIMChief Financial Officer↗
- Aug 28, 26Buy$2KAmy Suzon Chappell↗
- Aug 28, 26Buy$10KJoseph M PalumboChief Medical Officer↗
- Aug 27, 26Buy$32KCUONG DO VPresident & CEO↗
- Aug 7, 25Buyamount n/aCUONG DO VPresident & CEO↗
- Mar 4, 24Buyamount n/aCUONG DO VPresident & CEO↗
- Dec 1, 23Sell$128KSTEVE GORLIN↗
- Nov 30, 23Buy$18KCUONG DO VPresident & CEO↗
- Sep 5, 23Sell$26KSTEVE GORLIN↗
- Aug 22, 23Sell$38KRICHARD J BERMAN↗
- Jun 7, 23Sell$35KRICHARD J BERMAN↗
- May 22, 23Sell$33KRICHARD J BERMAN↗
There are 3 more transactions in this stretch.
Stock compensation, tax and giftsshow the 25 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Nov 20, 24Compensationamount n/aRICHARD J BERMAN↗
- Nov 20, 24Compensationamount n/aSIGMUND ROGICH↗
- Jun 24, 24Compensationamount n/aCUONG DO VPresident & CEO↗
- Jun 24, 24Tax$20KCUONG DO VPresident & CEO↗
- Jun 24, 24Compensationamount n/aJOANNE WENDY KIMChief Financial Officer↗
- Jun 24, 24Tax$9KJOANNE WENDY KIMChief Financial Officer↗
- Jun 24, 24Compensationamount n/aJoseph M PalumboChief Medical Officer↗
- Jun 24, 24Tax$14KJoseph M PalumboChief Medical Officer↗
- Feb 15, 24Tax$6KCUONG DO VPresident & CEO↗
- Feb 15, 24Tax$3KJOANNE WENDY KIMChief Financial Officer↗
- Feb 15, 24Tax$3KJoseph M PalumboChief Medical Officer↗
- Dec 11, 23Compensationamount n/aJOANNE WENDY KIMChief Financial Officer↗
- Nov 9, 23Compensationamount n/aRICHARD J BERMAN↗
- Nov 9, 23Compensationamount n/aRobert J Hariri↗
- Nov 9, 23Compensationamount n/aSIGMUND ROGICH↗
- Nov 9, 23Compensationamount n/aSTEVE GORLIN↗
- Jun 29, 23Compensationamount n/aCUONG DO VCEO & President↗
- Jun 21, 23Compensationamount n/aCUONG DO VCEO & President↗
- Feb 16, 23Tax$27KCUONG DO VPresident & CEO↗
- Feb 16, 23Tax$14KJOANNE WENDY KIMChief Financial Officer↗
- Feb 16, 23Tax$14KJoseph M PalumboChief Medical Officer↗
- Feb 16, 23Tax$15KPENELOPE MARKHAMEVP Liver Cirrhosis R&D↗
- Feb 16, 23Tax$15KCHRISTOPHER READINGEVP Neuroscience R&D↗
- Feb 16, 23Tax$15KClarence N. AhlemEVP Neuroscience Product Dev.↗
- Feb 16, 23Tax$30KCUONG DO VCEO & President↗
The full record holds 52 transactions and goes back to Nov 23, 22.
Its sector and its market
BioVie Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From BioVie Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow BioVie Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 457 documents on file, from Aug 15, 2013 to Sep 28, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.